Sign in
Taking people in United StatesNo phase

SeeMe: Using Automated Facial Tracking to Detect Voluntary Behavior in Brain Injury

Key facts

Who runs it
Stony Brook University
Where
Stony Brook, United StatesSee the site
Trial code
Status
Recruiting
People taking part
80 people, planned
Started
30 Mar 2026
Expected to end
Dec 2029
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • SeeMe Multimodal Auditory Command Protocol
Record updated
5 May 2026

Who can take part

Age
22 years to 85 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 34 criteriaShow less

Who can take part

  • Adults (22+) with a history of acute traumatic brain injury
  • Documented loss of consciousness with a Glasgow Coma Scale (GCS) score less than or equal to 8 upon hospitalization
  • Clinically stable as determined by the primary neurosurgery or ICU team
  • Intact auditory pathways as confirmed by BAERs
  • Family consent for study participation
  • Adults 22+ with no history of neurological or psychiatric disorders
  • Normal baseline neurological examination
  • Intact auditory pathways
  • Ability to provide informed consent
  • Ability to follow simple auditory commands in English
  • Adults (22+) undergoing elective spine surgery
  • Requirement of general anesthesia and pharmacological paralysis (neuromuscular blockade) as part of the standard surgical procedure
  • Clinically stable for study procedures as determined by the anesthesia and surgical teams
  • Intact auditory pathways
  • Ability to provide informed pre-operative consent

Who cannot take part

  • Any previous history of traumatic brain injury
  • Any previous history of severe traumatic brain injury (TBI)
  • Any previous history of severe traumatic brain injury
  • Significant baseline facial or hand motor deficits prior to the administration of anesthesia
  • Hearing Impairment confirmed via absence of Brainstem Auditory Evoked Responses (BAERs) that would prevent the patient from hearing the auditory commands
  • Any other medical condition that, in the judgment of the investigator, makes participation in the study unsafe
  • Any neurodegenerative disease such as dementia; Group 2: Healthy Control Cohort
  • Hearing Impairment that would prevent the participant from hearing the auditory commands
  • Any neurodegenerative disease (e.g., dementia)
  • Any motor impairment (e.g., facial palsy, carpal tunnel syndrome) that would interfere with facial or hand movement tracking
  • Any other medical condition that, in the judgment of the investigator, makes participation in the study unsafe
  • Hearing Impairment that would prevent the patient from hearing the auditory commands
  • Any neurodegenerative disease such as dementia
  • Any other medical condition that, in the judgment of the investigator, makes participation in the study unsafe
  • No legal authorized representative (LAR) available to provide informed consent for the patients in a comatose state
  • Pregnant women
  • Pregnant women; Group 3: Sedated/Anesthetized Cohort
  • Pregnant women

Other criteria

  • Group 1: Traumatic Brain Injury (TBI) Cohort

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 22 and 85 years old?

Where in United States

  • Stony Brook University HospitalStony Brook, United StatesContact: Sima Mofakham, PhDTaking people

About the trial

What the trial wants to find out

Objective: This prospective interventional study introduces "SeeMe," an automated, high-resolution computer vision platform designed to objectively quantify microscopic, auditory command-evoked movements in patients with Traumatic Brain Injury (TBI). Current clinical assessments, such as the Glasgow Coma Scale (GCS) and Coma Recovery Scale-Revised (CRS-R), rely on subjective human observation and often fail to detect low-amplitude motor responses, potentially misclassifying up to 25% of patients as unresponsive.

Read full original descriptionShow less

Methodology: SeeMe utilizes vector analysis, cross-correlation, and deep neural networks (DNNs) to track individual facial pores and hand movements with sub-millimeter precision (0.5 mm) and high temporal resolution (0.03s). The study will enroll a cohort of 60-80 TBI patients, alongside healthy controls and pharmacologically paralyzed subjects, to validate SeeMe's sensitivity and specificity.

Primary Goals:

1. Validation: Compare SeeMe's detection of voluntary motor recovery against gold-standard clinical examinations (CRS-R). 2. Synchronization: Simultaneously record and time-lock electroencephalography (EEG) and electrocorticography (ECoG) with SeeMe-detected movements. 3. Biomarker Identification: Characterize neural signatures (specifically Beta-band oscillations) associated with the return of voluntary behavior.

Impact: By providing a real-time, objective measure of motor intention and execution, SeeMe aims to identify "Cognitive-Motor Dissociation" (CMD) earlier than current methods, facilitating more accurate prognostications and laying the framework for future closed-loop neuromodulation (e.g., Vagus Nerve Stimulation) to accelerate TBI recovery.

The 3 groups in the trial

  • TBI PatientsTreatment being tested

    Patients with Traumatic Brain Injury receiving the SeeMe Auditory Stimulation protocol daily to detect covert motor responses

    Treatment: SeeMe Multimodal Auditory Command Protocol

  • Healthy Control CohortExisting treatment, for comparison

    Awake, healthy volunteers receiving the SeeMe protocol to establish "ground truth" for normal voluntary motor signatures and algorithm sensitivity.

    Treatment: SeeMe Multimodal Auditory Command Protocol

  • Sedated/Paralyzed PatientsSham treatment, for comparison

    Patients undergoing general anesthesia and pharmacological paralysis receiving the SeeMe protocol to establish the algorithm's specificity and "noise floor."

    Treatment: SeeMe Multimodal Auditory Command Protocol

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
SeeMe: A Multimodal Behavioral-Electrophysiological Tool for Real-Time Detection of Motor Behavior in Brain Injury Patients
Fit questions
Built from NCT07560631, who can take part
Record updated
5 May 2026